4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-22-030008
Chief Scientific Officer acquired 11,588 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sethuraman Natarajan · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-01 | Grant or award : show line 1 in the form | +11,588 | 156,350 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-01 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +69,525 | 69,525 | D |
Loading xslF345X03/tm228284-4_4seq1.xml…